# ALY688-SR in Generally Healthy Overweight or Obese Adults

> **NCT04855565** · PHASE1 · TERMINATED · sponsor: **Allysta Pharmaceutical** · enrollment: 8 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** ALY688-SR

## Key facts

- **NCT ID:** NCT04855565
- **Lead sponsor:** Allysta Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-19
- **Primary completion:** 2021-08-03
- **Final completion:** 2021-08-03
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Inability to recruit due to COVID-19 pandemic restrictions
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855565, "ALY688-SR in Generally Healthy Overweight or Obese Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04855565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*